首页> 美国卫生研究院文献>Journal of Bone and Mineral Research >Inhibition of CaMKK2 Enhances Fracture Healing by Stimulating Indian Hedgehog Signaling and Accelerating Endochondral Ossification
【2h】

Inhibition of CaMKK2 Enhances Fracture Healing by Stimulating Indian Hedgehog Signaling and Accelerating Endochondral Ossification

机译:CaMKK2的抑制通过刺激印度刺猬信号并加速内软骨骨化来增强骨折愈合。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Approximately ten percent of all bone fractures do not heal, resulting in patient morbidity and healthcare costs. However, no pharmacological treatments are currently available to promote efficient bone healing. Inhibition of Ca2+/calmodulin (CaM)-dependent protein kinase kinase 2 (CaMKK2) reverses age-associated loss of trabecular and cortical bone volume and strength in mice. In the current study, we investigated the role of CaMKK2 in bone fracture healing and show that its pharmacological inhibition using STO-609 accelerates early cellular and molecular events associated with endochondral ossification, resulting in a more rapid and efficient healing of the fracture. Within 7 days post-fracture, treatment with STO-609 resulted in enhanced Indian hedgehog signaling, paired-related homeobox (PRX1)-positive mesenchymal stem cell recruitment, chondrocyte differentiation and hypertrophy, along with elevated expression of osterix, vascular endothelial growth factor and type 1 collagen at the fracture callus. Early deposition of primary bone by osteoblasts resulted in STO-609 treated mice possessing significantly higher callus bone volume by 14 days following fracture. Subsequent rapid maturation of the bone matrix bestowed fractured bones in STO-609 treated animals with significantly higher torsional strength and stiffness by 28 days post-injury, indicating accelerated healing of the fracture. Previous studies indicate that fixed and closed femoral fractures in the mice take 35 days to fully heal without treatment. Therefore, our data suggest that STO-609 potentiates a 20% acceleration of the bone healing process. Moreover, inhibiting CaMKK2 also imparted higher mechanical strength and stiffness at the contralateral cortical bone within 4 weeks of treatment. Taken together, the data presented here underscore the therapeutic potential of targeting CaMKK2 to promote efficacious and rapid healing of bone fractures and as a mechanism to strengthen normal bones.
机译:所有骨折中约有百分之十无法愈合,导致患者发病率和医疗费用增加。但是,目前没有药物治疗可用于促进有效的骨愈合。抑制Ca 2 + /钙调蛋白(CaM)依赖性蛋白激酶激酶2(CaMKK2)可逆转小鼠与年龄相关的小梁和皮质骨体积和强度的损失。在当前的研究中,我们调查了CaMKK2在骨折愈合中的作用,并显示使用STO-609抑制其药理作用可加速与软骨内骨化相关的早期细胞和分子事件,从而使骨折更快速有效地愈合。骨折后7天内,使用STO-609进行治疗可增强印度刺猬信号传导,配对相关的同源盒(PRX1)阳性的间充质干细胞募集,软骨细胞分化和肥大,以及osterix,血管内皮生长因子和骨折call骨处的1型胶原蛋白。成骨细胞早期沉积初级骨,导致STO-609处理的小鼠在骨折后14天具有明显更高的骨call骨量。骨基质的快速成熟赋予了经STO-609处理的动物骨折的骨骼,在受伤后28天时其抗扭强度和刚度显着提高,表明骨折愈合加快。先前的研究表明,小鼠固定和闭合的股骨骨折需要35天才能完全愈合,无需治疗。因此,我们的数据表明STO-609可以使骨骼愈合过程加速20%。此外,在治疗的4周内,抑制CaMKK2也可在对侧皮质骨处赋予较高的机械强度和刚度。综上所述,此处提供的数据强调了靶向CaMKK2可以促进骨折的有效和快速愈合以及作为增强正常骨骼的机制的治疗潜力。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号